All Companies

MRK

Merck & Co., Inc.

Pharmaceutical Preparations

$146.87updated Sep 19, 2026

Congressional trading profile for Merck & Co., Inc. (MRK), covering 41 disclosed transactions by 18 lawmakers.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Total Trades

41

Politicians Trading

18

Last Traded

Aug 24, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Maria Elvira SalazarRSep 9, 2026Aug 19, 2026Buy$15,001 - $50,000-3.50%
Maria Elvira SalazarRSep 9, 2026Aug 19, 2026Buy$15,001 - $50,000-3.50%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$15,001 - $50,000+22.77%
Sheri BiggsROct 5, 2025Mar 19, 2025Sell$15,001 - $50,000+56.21%
Lisa C. McClainRSep 12, 2025Aug 4, 2025Sell$1,001 - $15,000+83.91%
Marjorie Taylor GreeneRAug 29, 2025Aug 28, 2025Buy$1,001 - $15,000+76.51%
Lisa C. McClainRAug 13, 2025Jun 24, 2025Buy$1,001 - $15,000+82.86%
Scott FranklinRJul 14, 2025Jun 16, 2025Sell$1,001 - $15,000+81.41%
Robert BresnahanRMay 31, 2025May 15, 2025Sell$15,001 - $50,000+96.35%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+88.66%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Sell$15,001 - $50,000+88.29%
Robert BresnahanRMay 8, 2025Apr 8, 2025Buy$15,001 - $50,000+86.03%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+77.29%
Bruce WestermanRApr 16, 2025Mar 3, 2025Buy$1,001 - $15,000+57.67%
Marjorie Taylor GreeneRApr 11, 2025Apr 9, 2025Buy$1,001 - $15,000+79.31%
Robert BresnahanRMar 27, 2025Feb 25, 2025Sell$15,001 - $50,000+60.64%
Jefferson ShreveRMar 9, 2025Feb 24, 2025Buy$15,001 - $50,000+60.92%
Byron DonaldsRFeb 10, 2025Jan 16, 2025Sell$1,001 - $15,000+45.85%
Byron DonaldsRFeb 10, 2025Jan 16, 2025Sell$1,001 - $15,000+45.85%